PROTECT AKTIENANLEIHE - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU8J9S4

Market Closed - Deutsche Boerse AG 19:01:00 10/05/2024 BST
100.2 EUR +0.19% Intraday chart for PROTECT AKTIENANLEIHE - FRESENIUS MEDICAL CARE
Current month+0.65%
1 month+6.38%
Date Price Change Volume
10/05/24 100.2 +0.19% 0
09/05/24 100.1 -0.21% 0
08/05/24 100.3 +0.42% 0
07/05/24 99.85 +0.06% 0
06/05/24 99.79 +0.32% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 07:01 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU8J9S
ISINDE000VU8J9S4
Date issued 15/06/2023
Strike 50
Maturity 21/06/2024 (40 Days)
Parity 0.05 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 102.5
Lowest since issue 79.5

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
40.4 EUR
Average target price
39.45 EUR
Spread / Average Target
-2.34%
Consensus